Summer Sale
50% off Premium Yearly
Opinions Daniel Straus
Horizon's Medical MarijuanaHMMJ.TORISKYMay 16, 2018
Daniel StrausStock price when the opinion was issued
As of Jun 19, 2026. Market Open.
You might be interested:
This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.
HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.
This ETF is better than holding any individual company as it offers better diversification including some of the smaller producers. His view that these niche sector ETFs should be viewed as a speculative holding as many of the holdings are not even showing positive earnings yet. MER is 0.75%. It is a little early to consider this as a long term holding.